WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Events
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

WSGR Events

5.14.26

Biotech's New Playbook: Spinouts and Optionality
Biotechnology companies are increasingly using single-asset spinouts as a way to create value, though the approach can be complex. This afternoon forum will examine considerations to strategically design and execute a successful spinout. Attendees will gain insight into the legal foundations of these transactions, including tax considerations, patent strategy, IP allocation, and structural design. The program will also explore the broader business drivers behind spinout decisions—such as capital formation, strategic focus, partnership alignment, governance, and long-term value creation.
Speaking Engagements

11.20.25

OIS Ignite: Ophthalmology Startup Workshop — San Diego
Wilson Sonsini is pleased to participate in the inaugural OIS Ignite Startup Workshop taking place in San Diego on November 20, 2025. OIS Ignite is a focused, full-day program designed to support ophthalmology start-ups as they navigate the most critical challenges from early development through commercialization. Through expert panels, real-world examples, and peer exchange, this event addresses the complex journey of bringing innovation to market, across both anterior and posterior segment therapies.
Affiliated Programs

3.13.25

2025 Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah
Wilson Sonsini is looking forward to the 2025 Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office. Now in its 12th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs, and the investor community.
Speaking Engagements

1.13.25

Biologic Summit 2025
Matt Bresnahan will be speaking at the inaugural BioLogic Summit this January in San Diego. His session, "Developing and Implementing an Effective IP Strategy for AI/ML-Driven Biologics," will cover key topics like understanding IP rights, inventorship, and ownership of AI/ML-based inventions, along with strategies for protecting platform innovations and therapeutic modalities.  He will also review life cycle management strategy for a biologics therapeutic program and Freedom to Operate.
WSGR Events

6.13.24

Wilson Sonsini’s 31st Annual Medical Device & Digital Health Conference
Wilson Sonsini Goodrich & Rosati’s 31st Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2023’s fundraising and deals, and how 2024 is shaping up along with partnering strategies in the current market.
Affiliated Programs

11.02.23

Biocom San Diego CEO Summit
Wilson Sonsini is proud to sponsor the Biocom California CEO Summit In San Diego, CA, the premier conference designed exclusively for CEOs in the life science industry.
WSGR Events

6.15.23

Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference
Wilson Sonsini’s 30th Annual Medical Device Digital Health Conference will address topics of critical importance to medical device and digital health companies today, including key healthcare regulatory considerations, the relationship between intellectual property and valuation, a look back at 2022’s fundraising and deals, and how 2023 is shaping up along with partnering strategies in the current market.
Affiliated Programs

6.14.23

2023 First Look SoCal Innovation Showcase
Wilson Sonsini is pleased to support the Alliance for SoCal Innovation’s The First Look SoCal Innovation Showcase 2023. The First Look SoCal Innovation Showcase is an annual conference celebrating the best very early-stage startups commercializing deep tech and life science breakthroughs from SoCal’s top research institutions. The primary goal is to connect founders with investors, mentors, and corporate executives with invaluable subject matter expertise to provide credible guidance and pre-seed/seed stage funding crucial to making the often-perilous journey from lab to market. Wilson Sonsini is a lead sponsor.
Affiliated Programs

3.16.23

Entrepreneur & Investor Summit 2023
Wilson Sonsini is proud to sponsor Utah’s premier event for life sciences entrepreneurs and investors presented by BioUtah, BioHive, and PIVOT Center. Join us at this year’s Entrepreneur & Investor Summit to hear industry experts speak on compelling topics such as funding, operating, and developing life sciences companies. Financing options for angel, early and later-stage companies will also be presented. Companies will have the opportunity to apply to pitch to investors. Don’t miss this chance to network with notable industry members and learn about investment opportunities in Utah’s life sciences companies.
Affiliated Programs

1.31.23

What You Missed at JPM 2023
Don't miss this opportunity to get caught up on the takeaways from this year's annual J.P. Morgan Healthcare Conference. One of the largest and most informative healthcare investment symposiums in the industry, the conference brings together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community where they discuss high-level strategies in this rapidly changing market. Get a full rundown of the deals and data, while gaining ideas to start the year.
Speaking Engagements

11.02.22

Greater Los Angeles CEO Summit 2022
Matt Bresnahan joins the panel discussion "The Value of Partnerships and How to Navigate Them" with Alborz Mahdavi, Vice President, Protomer Technologies, Eli Lilly and Company; Andrew Korytko, Head of Biotechnology External Innovation, Eli Lilly and Company; Aubrey Kelly, CEO & Co-Founder, Rabble Health; moderated by Bassil Dahiyat, CEO, Xencor.
WSGR Events

5.25.22

Startup Bootcamp for Entrepreneurs
Wilson Sonsini is pleased to partner with Biohive, BioUtah, and The University of Utah PIVOT Center to host a Startup Bootcamp for Entrepreneurs. This is an exclusive one-day program designed for those in the process of—or considering—starting a new venture. Join us for this unique event that will provide practical information on the most important legal and business issues facing today’s entrepreneurs.
  • 1
  • 2
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.